AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MEDICA GROUP PLC

Director's Dealing Apr 20, 2017

4972_dirs_2017-04-20_4e7e394d-e6f5-437e-a6d1-0d66a5cc2307.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9035C

Medica Group PLC

20 April 2017

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC ("Company") announces that on 19 April 2017 an option was granted under the Medica Group PLC Sharesave Scheme to a PDMR.

The option was granted with an exercise price of 186p per share, and is exercisable after the maturity of an associated three year savings contract.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

1. Details of PDMR
(a) Name Kevin Patrick Terrins
2. Reason for notification
(b) Position / status Business Development Director
(c) Initial notification / amendment Initial notification
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Grant of an option to acquire Shares
(c) Price(s) and volume 9,677 Shares, with an exercise price of 186p per share
(d) Aggregated information N/A
(e) Date of the transaction 19 April 2017
(f) Place of the transaction Outside a trading venue

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKKDBQBKDAQB

Talk to a Data Expert

Have a question? We'll get back to you promptly.